@article{addaba02039242ddbca617d3c117ea02,
title = "American Academy of Allergy, Asthma \& Immunology Work Group Report: Exercise-induced asthma",
author = "Weiler, \{John M.\} and Sergio Bonini and Robert Coifman and Timothy Craig and Lu{\'i}s Delgado and Miguel Cap{\~a}o-Filipe and Desiderio Passali and Christopher Randolph and William Storms",
note = "Funding Information: S.B. is in part supported by grants from the Italian Ministry of Health, Commission for Vigilance and Doping, the Italian Institute of Health, and the European Commission Network of Excellence GA 2 LEN-FOOD-CT-2004-506378. Funding Information: Disclosure of potential conflict of interest: J. M. Weiler owns stock in, has patent licensing arrangements with, and is employed by CompleWare Corporation and Iowa Clinical Research Corporation. S. Bonini has consulting arrangements with Lofarma, Almirall, and Pfizer; has received grant support from Almirall, Bioallergy, Lofarma, and Schering-Plough; is employed as a member of the Research and Development Commission of the Italian Drug Agency; and is on the speakers' bureau for Alcon, Allergopharma, Allergy Therapeutics, ALK-Albell{\'o}, Almirall, Aventis, Sanofi-Synthelabo, Stallergens, UCB, and Zambon. R. Coifman is employed by Allergy and Asthma of South Jersey. D. Passali has consulting arrangements with Lofarma, Sanofi-Aventis, and Angelini and is on the speakers' bureau for Schering-Plough, Valeas, GlaxoSmithKline, Mercury, and Amplifon. C. Randolph is on the speakers' bureau for GlaxoSmithKline, Schering-Plough, Novartis, Genentech, Merck, and AstraZeneca. W. Storms has consulting arrangements with Adams, Alco, Altana, AstraZeneca, Consumer Reports/Consumer Union, Efficas, Exaeris, Genentech, Greer, GlaxoSmithkline, Hoffman, Laroche, Inspire, Isis, Ivax, King, Medpointe, Merck, Nexcura, Novartis, Sanofi-Aventis, Schering-Plough, Sepracor, Strategic Biosciences, Strategic Pharmaceutical Advisors, TREAT Foundation, and Wyeth; owns stock in Strategic Biosciences, Strategic Pharmaceutical Advisors, and Exaeris; has patent licensing arrangements with Strategic Biosciences; has received grant support from Alcon, Altana, AstraZeneca, BMS, Genentech, GlaxoSmithKline, Medpointe, Merck, Novartis, Sanofi-Aventis, and Schering-Plough; and is on the speakers' bureau for Abbott, Alco, AstraZeneca, Genentech, Medpointe, Merck, Novartis, Pfizer, Sanofi-Aventis, and Schering-Plough. The other authors have declared that they have no conflict of interest. ",
year = "2007",
month = jun,
doi = "10.1016/j.jaci.2007.02.041",
language = "English (US)",
volume = "119",
pages = "1349--1358",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Elsevier Inc.",
number = "6",
}